http://purplestride.org/find_a_local_event.html
4th leading cause of cancer death in US
from Pancreatic Cancer Action Network
1500 Rosecrans Avenue, Suite 200, Manhattan Beach, CA 90266 Toll Free: 877-272-6226 Phone: 310-725-0025 Fax: 310-725-0029
Does the body reduce estrogen production with increased mushroom intake?
gsearch P.I.: Melanie Palomares, MD, MS studies
Palomares and colleagues will recruit 24 postmenopausal breast cancer survivors for this study. Women who were diagnosed with breast cancer five or more years ago and remain free of disease will be randomly assigned to take tablets containing varying doses of freeze-dried white button mushrooms daily for 12 weeks.
Researchers will monitor aromatase activity and female hormones in participants, as well as levels of what are called conjugated linoleic acids, a group of compounds in the mushrooms that appear to be responsible for their anticancer properties. They also will study effects on the immune system, cholesterol and bone health.
A second planned trial, meanwhile, will address prostate cancer. more
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction (LDTam)
Palomares and colleagues will recruit 24 postmenopausal breast cancer survivors for this study. Women who were diagnosed with breast cancer five or more years ago and remain free of disease will be randomly assigned to take tablets containing varying doses of freeze-dried white button mushrooms daily for 12 weeks.
Researchers will monitor aromatase activity and female hormones in participants, as well as levels of what are called conjugated linoleic acids, a group of compounds in the mushrooms that appear to be responsible for their anticancer properties. They also will study effects on the immune system, cholesterol and bone health.
A second planned trial, meanwhile, will address prostate cancer. more
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction (LDTam)
Cost of genetic testing -- and factoring in court cases
From twitter's @SusanneUre : U.S courts invalidates patent that prevents women from identifying breast cancer. http://bit.ly/d0D (original link at womensrights.change.org ).
Some Cancers Directly Related to Inflammatory Conditions
Page 36, Table 2 of David Servan-Schreiber's Anti Cancer: A New Way of Life (English 2008)
citing Balkwill & Mantovani "Inflammation and Cancer: Back to Virchow?" (The Lancet 2001) NIH abstract
List of ten.
citing Balkwill & Mantovani "Inflammation and Cancer: Back to Virchow?" (The Lancet 2001) NIH abstract
List of ten.
Heard it on the grapevine -- how helpful is CA-125 blood test for Ovarian Cancer detection? What is a screening test?
this is the first person link from 27 June 2002 from Carolyn Benivegna about her advocacy education group subsequent to her illness and recovery:
http://ovariancancer.jhmi.edu/stories2.cfm?personID=15&order=alpha
It is hosted at Johns Hopkins, an NCI designated cancer center, under personal stories.
Another source of info is the gov't run 1 800 4 cancer at NIH .
Our gov't does a wonderful job in providing info on cancers, standard treatments, and opportunities to participate in trials.
This is a year 2000 update: http://www.baymoon.com/~gyncancer/library/blcarolyn2.htm
that corrects the record. CA-125 is not a screening test akin to the PSA for men.
Here's a link from snopes with the original, erroneous note from Carolyn:
http://www.snopes.com/medical/disease/ca125.asp , written in the name of Kathy. The Mikkelson's have included a link to an undated informational article from Johns Hopkins:
http://web.archive.org/web/20060421224244/http://ovariancancer.jhmi.edu/ca125qa.cfm
The take-home message is to know the symptoms and where to take these for getting a diagnosis.
The other take home message is to understand how easily unhelpful information can spread on the internet: http://www.google.com/search?sourceid=navclient&ie=UTF-8&rlz=1T4SNYC_enUS311&q=ca-125+snopes
This article contains criteria for evaluating whether a test is reliable and predictive enough to be a screening test: http://www.blackhealthcare.com/BHC/Articles/Article5a.asp
http://ovariancancer.jhmi.edu/stories2.cfm?personID=15&order=alpha
It is hosted at Johns Hopkins, an NCI designated cancer center, under personal stories.
Another source of info is the gov't run 1 800 4 cancer at NIH .
Our gov't does a wonderful job in providing info on cancers, standard treatments, and opportunities to participate in trials.
This is a year 2000 update: http://www.baymoon.com/~gyncancer/library/blcarolyn2.htm
that corrects the record. CA-125 is not a screening test akin to the PSA for men.
Here's a link from snopes with the original, erroneous note from Carolyn:
http://www.snopes.com/medical/disease/ca125.asp , written in the name of Kathy. The Mikkelson's have included a link to an undated informational article from Johns Hopkins:
http://web.archive.org/web/20060421224244/http://ovariancancer.jhmi.edu/ca125qa.cfm
The take-home message is to know the symptoms and where to take these for getting a diagnosis.
The other take home message is to understand how easily unhelpful information can spread on the internet: http://www.google.com/search?sourceid=navclient&ie=UTF-8&rlz=1T4SNYC_enUS311&q=ca-125+snopes
This article contains criteria for evaluating whether a test is reliable and predictive enough to be a screening test: http://www.blackhealthcare.com/BHC/Articles/Article5a.asp
Look, ma. No spleen! (asplenia, Dx 759.0)
http://www.survivorshipguidelines.org/pdf/SplenicPrecautions.pdf
Health Link
Healthy living after treatment for childhood cancer
Splenic Precautions
Version 2.0 - 3/06
Copyright 2006 © Children’s Oncology Group
All rights reserved worldwide Page 4 of 5
Wallet Card for Patients Without a Functioning Spleen
Written by Teresa Sweeney, RN, MSN, CPNP, After Completion of Therapy (ACT) Clinic, St. Jude
Children’s Research Hospital, Memphis, TN.
Reviewed by Smita Bhatia, MD, MPH, Julie Blatt, MD, Melissa M. Hudson, MD, Kevin Oeffinger, MD, Lise
Yasui, Wendy Landier, CPNP, Lisa Bashore, MS, RN, CPNP, CPON® and the COG Late Effects Committee.
Illustrated by Devika Bhatia.
Medical Alert: Asplenic Patient
This patient is asplenic and at risk for potentially fatal, overwhelming
infections. Immediate medical attention is required for fever of >101��F
(38.3��C) or other signs of serious illness. Suggested management
includes:
1) Physical exam, CBC and blood culture.
2) Administration of a long-acting, broad-spectrum parenteral antibiotic
(e.g., ceftriaxone) accompanied by close clinical monitoring while
awaiting blood culture results.
3) Hospitalization and broadening of antimicrobial coverage (e.g.,
addition of vancomycin) may be necessary under certain
circumstances, such as the presence of marked leukocytosis,
neutropenia, or significant change from baseline CBC; toxic clinical
appearance; fever >104��F; meningitis, pneumonia, or other serious
focus of infection; signs of septic shock; or previous history of
serious infection.
MEDICAL ALERT:
Asplenic Patient
Patient Name: ________________________
Physician Name: ________________________
Physician Phone: ________________________
Health Link
Healthy living after treatment for childhood cancer
Splenic Precautions
Version 2.0 - 3/06
Copyright 2006 © Children’s Oncology Group
All rights reserved worldwide Page 4 of 5
Wallet Card for Patients Without a Functioning Spleen
Written by Teresa Sweeney, RN, MSN, CPNP, After Completion of Therapy (ACT) Clinic, St. Jude
Children’s Research Hospital, Memphis, TN.
Reviewed by Smita Bhatia, MD, MPH, Julie Blatt, MD, Melissa M. Hudson, MD, Kevin Oeffinger, MD, Lise
Yasui, Wendy Landier, CPNP, Lisa Bashore, MS, RN, CPNP, CPON® and the COG Late Effects Committee.
Illustrated by Devika Bhatia.
Medical Alert: Asplenic Patient
This patient is asplenic and at risk for potentially fatal, overwhelming
infections. Immediate medical attention is required for fever of >101��F
(38.3��C) or other signs of serious illness. Suggested management
includes:
1) Physical exam, CBC and blood culture.
2) Administration of a long-acting, broad-spectrum parenteral antibiotic
(e.g., ceftriaxone) accompanied by close clinical monitoring while
awaiting blood culture results.
3) Hospitalization and broadening of antimicrobial coverage (e.g.,
addition of vancomycin) may be necessary under certain
circumstances, such as the presence of marked leukocytosis,
neutropenia, or significant change from baseline CBC; toxic clinical
appearance; fever >104��F; meningitis, pneumonia, or other serious
focus of infection; signs of septic shock; or previous history of
serious infection.
MEDICAL ALERT:
Asplenic Patient
Patient Name: ________________________
Physician Name: ________________________
Physician Phone: ________________________
When an attorney contacts you about possible class action suit
Here is an example of flyers you might receive. These are in reference to the Beverly Hils High School oil well lawsuit promulgated by Masry & Vititoe in March 2003, then later by Baron & Budd in April 2003. They contended that there was an enviornmental--rather than a statistical or genetic or infectious--cause for a cluster of Hodgkin's Disease diagnoses. (Compare to Albany High School, Vianu 197 , Lancet)
In 2003, the University of Southern California Keck School of Medicine published a "Community Cancer Assessment Regarding Beverly Hills, California" which failed to support Masry's claims.[15]
Subscribe to:
Posts (Atom)
